The phrase, emerging from Southeast Asia, is the best way to describe the market action on Monday. The S&P 500 rose 0.2% while the tech-heavy Nasdaq was up 0.1%. Investors had seen the S&P 500 and Nasdaq finish at a record last week as well.
The phrase, emerging from Southeast Asia, is the best way to describe the market action on Monday. The S&P 500 rose 0.2% while the tech-heavy Nasdaq was up 0.1%. Investors had seen the S&P 500 and Nasdaq finish at a record last week as well.
MILLBRAE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today reported first quarter 2026 financial results and provided updates on its lead clinical programs.
MILLBRAE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today reported first quarter 2026 financial results and provided updates on its lead clinical programs.
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today reported financial results and business highlights for the first quarter ended March 31, 202...
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today reported financial results and business highlights for the first quarter ended March 31, 2026.
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the first quarter ended March 31, 2026, along with recent business updates and anti...
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the first quarter ended March 31, 2026, along with recent business updates and anticipated milestones. “Since our March update, execution has focused on turning CBeyond into a Phase 2b-ready development program,” said Punit Dhillon, President & CEO of Skye. “We have now initiated enrollment of Cohort 1 of the CBeyond Expansion Study, executed the compatibility and in-use study with ENHANZE to support a practical high-volume subcutaneous approach, and engaged external development advisors to help pressure-test our target product profile, dose-selection rationale and Phase 2b trial design. Our objective in 2026 remains focused on defining the dose and exposure that can support a larger Phase 2b study evaluating nimacimab as a complementary add-on approach for GLP-1-experienced patients.”
NEWTOWN SQUARE, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the first quarter ended March 31, 2026, and highlighted recent Company progress.
NEWTOWN SQUARE, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the first quarter ended March 31, 2026, and highlighted recent Company progress.
Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026
Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026
Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted agents
Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted agents
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter and year ended March 31, 2026.
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter and year ended March 31, 2026.
The following companies are expected to report earnings prior to market open on 05/12/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Sea Limited (SE)is reporting for the quarter ending March 31, 2026. The internet software company's consensus ear
The following companies are expected to report earnings prior to market open on 05/12/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Sea Limited (SE)is reporting for the quarter ending March 31, 2026. The internet software company's consensus ear
CUPERTINO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (“Ambow” or the “Company”) (NYSE American: AMBO) a U.S.-based innovator of AI-powered phygital (physical + digital) solutions for education, corporate collaboration and live events, today announced its unaudited financial and operating results for the three-month period ended March 31, 2026.
CUPERTINO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (“Ambow” or the “Company”) (NYSE American: AMBO) a U.S.-based innovator of AI-powered phygital (physical + digital) solutions for education, corporate collaboration and live events, today announced its unaudited financial and operating results for the three-month period ended March 31, 2026.
You may already know that claiming Social Security before your full retirement age (FRA) -- 67 for most people today -- can reduce your benefits by up to 30%. This increase is typically permanent, but there are a few exceptions. One of the most common applies to seniors who work while claiming Social Security early. This can cost them in the short term, but it can also lead to notable long-term ga...
You may already know that claiming Social Security before your full retirement age (FRA) -- 67 for most people today -- can reduce your benefits by up to 30%. This increase is typically permanent, but there are a few exceptions. One of the most common applies to seniors who work while claiming Social Security early. This can cost them in the short term, but it can also lead to notable long-term gains. Image source: Getty Images. Continue reading
The seven largest stockholdings of European sustainable investment funds are US technology companies led by Microsoft Corp. and Nvidia Corp. Of the funds’ top-10 holdings, just one is based in Europe: ASML Holding NV , according to research from Morgan Stanley . Amazon.com Inc. , Meta Platforms Inc. , Broadcom Inc. , Apple Inc. and Alphabet Inc. are the other US companies that continue to be widel...
The seven largest stockholdings of European sustainable investment funds are US technology companies led by Microsoft Corp. and Nvidia Corp. Of the funds’ top-10 holdings, just one is based in Europe: ASML Holding NV , according to research from Morgan Stanley . Amazon.com Inc. , Meta Platforms Inc. , Broadcom Inc. , Apple Inc. and Alphabet Inc. are the other US companies that continue to be widely held by European funds focused on environmental, social and governance factors. The Morgan Stanley report is based on an analysis of 240 of the region’s largest sustainable funds by assets under management. Tech stocks got a stark warning on Monday when Michael Burry , the investor made famous in The Big Short , said the group may be headed for a sharp reversal after a “parabolic” surge pushed valuations to unsustainable levels. The Nasdaq 100, which is loaded with tech stocks, soared 47% over the past year. Read More: Michael Burry Warns of Stock Crash as Tech Jump Echoes 2000 Peak While US tech stocks dominate, ASML and AstraZeneca Plc were overweight in European sustainable funds relative to market benchmarks and investors increased their “positioning” in the stocks during the first quarter, Morgan Stanley reported. US-listed Trane Technologies Plc , Lam Research Corp. and Applied Materials Inc. also saw a first-quarter “uptick in positioning and are active overweights” in European funds. As for flows, the analysts found that sustainable funds bounced back in Europe during the first quarter. A net $39 billion plowed into the funds after 2025 saw the sector’s first-ever net annual redemptions. Read More: Fund Managers Saw Historic Withdrawals From ESG Labels Last Year By contrast, investors withdrew money from sustainable funds in the US and Asia-Pacific region during the first quarter. A net $4.2 billion was pulled from US funds, while $3 billion was redeemed from APAC funds, reversing last year’s $1 billion of inflows, Morgan Stanley reported. (For more ESG news, clic...
Circle Internet Group (NYSE: CRCL) reported earnings early Monday morning, sending the stablecoin issuer's stock sharply higher. The gains peaked at 19.4% around 2:40 p.m. ET, and the stock was still up by a hefty 15% just before the closing bell. Image source: The Motley Fool. The USD Coin (CRYPTO: USDC) issuer's Q1 2026 report wasn't a clean sweep. $0.21 of diluted earnings per share exceeded Wa...
Circle Internet Group (NYSE: CRCL) reported earnings early Monday morning, sending the stablecoin issuer's stock sharply higher. The gains peaked at 19.4% around 2:40 p.m. ET, and the stock was still up by a hefty 15% just before the closing bell. Image source: The Motley Fool. The USD Coin (CRYPTO: USDC) issuer's Q1 2026 report wasn't a clean sweep. $0.21 of diluted earnings per share exceeded Wall Street's consensus target at $0.18 per share, but $694 million in revenues fell short of analysts' $715 million estimate. Continue reading